Navigation Links
'Open wide' for new stem cell potential
Date:8/22/2011

itive stem cells which have a high capacity to be transformed into different tissues. Prof. Pitaru and his fellow researchers have already succeeded in coaxing oral mucosa stem cells into becoming other significant cells, including bone, cartilage, muscle, and even neurons.

All this, says Prof. Pitaru, is derived from a miniscule biopsy of tissue, measuring 1 by 2 by 3 millimeters. "We are able to grow trillions of stem cells from this small piece of tissue," he explains. The site of the biopsy is readily accessible, and patients experience minimal discomfort and require almost no healing time. This makes the mouth a convenient site for harvesting stem cells.

A safe and effective alternative

Prof. Pitaru and his fellow researchers are currently in pre-clinical trials, implanting these stem cells into various tissues within small rodents. Their projects include researching the impact of the innovative cells as a treatment for chronic heart failure; neurodegenerative diseases; inflammatory autoimmune diseases such as Crohn's disease; and diabetes.

These diseases are most likely to affect the elderly, and the oral mucosa stem cells would offer a more safe and effective alternative to both embryonic and adult-derived stem cells. Despite their therapeutic potential, patients would be required to take immunosuppressant therapies when being treated with implanted embryonic cells to ensure that the body does not reject the foreign cells. Once implanted, embryonic stem cells often cause tumors to form, Prof. Pitaru says. "Stem cells taken from the tissue of elderly patients have growth limitations and reduced functional capacities."

Stem cells derived from the oral mucosa, however, avoid the pitfalls of their predecessors. Because they stay young, they behave as fetal cells, but there is no danger of rejection because they are taken directly from the patient. And they show no signs of developing the aggressive tumors tha
'/>"/>

Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. BIO-key(R) International To Exhibit at Oracle OpenWorld
2. Sentara begins international trial -- open at only 24 US locations
3. Vitamin K does not stem BMD decline in postmenopausal women with osteopenia
4. IronKey Opens New European Office
5. Singapore opens Fusionopolis, its second major R&D hub in 5 years
6. Nutrition and bone health session to open the IOF World Congress on Osteoporosis in Bangkok
7. Less than one month to opening of world’s largest global congress on osteoporosis
8. Climate change opens new avenue for spread of invasive plants
9. The Danisco Award 2008 goes to D.Sc. Barbara Ann Halkier from Faculty of Life Sciences, Copenhagen
10. Researchers recreate SARS virus, open door for potential defenses against future strains
11. Orangutans spontaneous whistling opens new chapter in study of evolution of speech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... MINNETONKA, Minn. , July 23, 2014 /PRNewswire/ ... technology company specializing in clinical study management systems, ... West , a proven life sciences industry executive ... named Chief Operating Officer (COO).  Clareece will be ... and sales growth, operational efficiency and quality product/service ...
(Date:7/23/2014)... hookworms and a protist called Blastocystis can be ... argues we should rethink our views of organisms that live ... co-author Julius Luke even ingested three developmental stages of a ... more than a year with the tapeworms, which might have ... now, he says he feels fine. , "I knew there ...
(Date:7/23/2014)... YORK, NY -- The New York Stem Cell Foundation ... to develop stem cell resources to investigate and explore ... Batten disease, a fatal illness affecting children. , NYSCF ... from skin samples of young people affected by juvenile ... cell lines are produced by artificially "turning back the ...
Breaking Biology News(10 mins):MedNet Appoints Clareece West As Chief Operating Officer 2Intestinal parasites are 'old friends,' researchers argue 2Intestinal parasites are 'old friends,' researchers argue 3NYSCF partners with Beyond Batten Disease Foundation to fight juvenile Batten disease 2NYSCF partners with Beyond Batten Disease Foundation to fight juvenile Batten disease 3
... in the United States will receive a diagnosis of breast ... cause of cancer-related death in women. Now a new test ... patient. "Our research shows that there is a subset ... at all, other than a lumpectomy," explains Philip Bernard, M.D., ...
... free, two-day colloquium begins February 12, 2009 with the ... originator of the modern theory of evolution of species ... foundation of all modern biology. The invited speakers provide ... and empirical research. As such, the symposium emphasizes how ...
... direct chemical modifications to specific sites on recombinant proteins ... pharmaceutical industry has been developed by Carolyn Bertozzi ... Lawrence Berkeley National Laboratory and the University of California ... diabetes, can be made in bacterial systems like ...
Cached Biology News:New test for breast cancer will help guide treatment choices 2Darwin's legacy in 21st century biology 2Tailor-made recombinant proteins in mammals 2Tailor-made recombinant proteins in mammals 3Tailor-made recombinant proteins in mammals 4
(Date:7/23/2014)... SAN ANTONIO , 23 de julio de ... ADBI (ADBI o la Compañía) ha anunciado hoy ... Akron (ABIA o el Instituto), ... de ADBI, un dispositivo de terapia de señal ...   El Instituto, que tiene una ...
(Date:7/23/2014)... , July 23, 2014 ... portfolio company of Trendlines Agtech , announced ... Israel,s leading agricultural thermoplastics ... Valentis,s technology combines nanocrystalline cellulose (NCC), ... waste, with additional nanoparticles to produce highly improved ...
(Date:7/23/2014)... , July 23, 2014 /PRNewswire/ - BioAmber Inc. ... company producing sustainable chemicals, today announced that the underwriters ... their option to purchase an additional 420,000 shares ... of $12.00 per share, less underwriting discounts and ... public offering of 2,800,000 shares of common stock, ...
(Date:7/23/2014)... Shire plc (LSE: SHP, ... biopharmaceutical company, and ArmaGen, a US privately held ... collaboration agreement for AGT-182, an investigational enzyme replacement ... the central nervous system (CNS) and somatic manifestations ... collaboration strengthens Shire,s rare disease pipeline of innovative ...
Breaking Biology Technology:ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 2ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 3ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 4ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 5ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 6Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 2BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 3Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 2Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 3Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 4Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 5
... Mass., March 11 Abt Associates announced it has ... United States Agency for International Development (USAID) to lead ... while protecting biodiversity in Mexico.Mexico is a member of ... 2000 mile border with the United States. USAID ...
... Pharma, Inc. (NYSE Alternext US: DDD) today reported financial ... 31, 2008. The Company will host a live ... (Eastern Daylight Time)."Last year was an important period for ... Ph.D., M.B.A. "Utilizing our unique CDT(R) platforms, we made ...
... State of Qatar to Introduce State-of-the-Art Treatments including ... the leading cancer centers in the Middle East ... Medical Systems (NYSE: VAR ) equipped ... Al Amal Hospital in Doha, Qatar, is replacing ...
Cached Biology Technology:USAID Selects Abt Associates to Lead Team in Strengthening Mexico Private Sector Competitiveness 2SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 2SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 3SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 4SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 5SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 6SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 7SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 8Leading Middle East Cancer Hospital Acquires Advanced Radiotherapy Capability from Varian Medical Systems 2Leading Middle East Cancer Hospital Acquires Advanced Radiotherapy Capability from Varian Medical Systems 3
... Phosphothioate (PTO) oligonucleotides: PTOs are ... the phosphate backbone is replaced by a ... against nuclease degradation. PTOs are available as ... are phosphothioates Oligonucleotides with thio-caps ...
The mini vertical flow workbench is designed to perform PCR protocols in a particle-free environment. The built-in UV light ensures the elimination of any nucleic acid to avoid cross-contamination....
... For microsatellite research, the 4300 System ... genotyping automation software available. SagaGT automates electrophoresis, ... band sizes, and allele scoring. ,Saga GT ... LI-COR. Saga 1.0 (Unix) was initially developed ...
MOUSE ANTI GTP BINDING PROTEIN...
Biology Products: